dalteparin has been researched along with Anemia, Hemolytic in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Anemia, Hemolytic: A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES).
| Excerpt | Relevance | Reference |
|---|---|---|
| " Comparing the rate of change between pairs of anti-Xa activity, the absorption rate was found to have decreased by over 50%." | 1.31 | The effect of plasmapheresis on the serum activity level of dalteparin: a case report. ( Sabloff, M; Wells, PS, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sabloff, M | 1 |
| Wells, PS | 1 |
1 other study available for dalteparin and Anemia, Hemolytic
| Article | Year |
|---|---|
The effect of plasmapheresis on the serum activity level of dalteparin: a case report.
Topics: Aged; Anemia, Hemolytic; Dalteparin; Female; Fibrinolytic Agents; Humans; Plasmapheresis | 2000 |